Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

JAK2 V617F Mutation Induces a Myeloproliferative Disorder in Mice.

Thomas G.P. Bumm, MD, Collin Elsea, Lisa G. Wood, RN, PhD, Daniel W. Sherbenou, Ian J. Griswold, PhD, Marc Loriaux, MD, PhD, Brian J. Druker, MD, Michael W. Deininger, MD, PhD

Blood (2005) 106 (11): 376.

https://doi.org/10.1182/blood.V106.11.376.376

Published: 2005

Journal Articles

In vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of Kit

Amie S. Corbin, Shadmehr Demehri, Ian J. Griswold, Yihan Wang, Chester A. Metcalf, III, Raji Sundaramoorthi, William C. Shakespeare, Joseph Snodgrass, Scott Wardwell, David Dalgarno, John Iuliucci, Tomi K. Sawyer, Michael C. Heinrich, Brian J. Druker, Michael W. N. Deininger

Blood (2005) 106 (1): 227–234.

https://doi.org/10.1182/blood-2004-12-4771

Published: 2005

Includes: Supplemental data

Journal Articles

Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970

Amie S. Corbin, Ian J. Griswold, Paul La Rosée, Kevin W. H. Yee, Michael C. Heinrich, Corinne L. Reimer, Brian J. Druker, Michael W. N. Deininger

Blood (2004) 104 (12): 3754–3757.

https://doi.org/10.1182/blood-2004-06-2189

Published: 2004

Journal Articles

Investigation of the Biological Differences between Bcr-Abl Kinase Mutations Resistant to Imatinib.

Ian J. Griswold, PhD, Thomas Bumm, MD, Thomas O’Hare, PhD, Erika M. Moseson, Brian J. Druker, MD, Michael W. Deininger, MD, PhD

Blood (2004) 104 (11): 555.

https://doi.org/10.1182/blood.V104.11.555.555

Published: 2004

Journal Articles

A Bcr-Abl Mutant Lacking Direct Binding Sites for the Grb2, Cbl and CrkL Adapter Proteins Fails to Induce Leukemia in Mice.

Kara J. Johnson, Ian J. Griswold, PhD, Amie Corbin, Michael W.N. Deininger, MD, PhD, Brian J. Druker, MD

Blood (2004) 104 (11): 718.

https://doi.org/10.1182/blood.V104.11.718.718

Published: 2004

Journal Articles

In Vitro and In Vivo Activity of the Src/Abl Kinase Inhibitor AP23464 and Analogs Against Activation Loop Mutants of KIT.

Amie S. Corbin, Shadmehr Demehri, Ian J. Griswold, Chester A. Metcalf, III, William C. Shakespeare, Joseph Snodgrass, Scott Wardwell, David C. Dalgarno, John Iuliucci, Tomi K. Sawyer, Brian J. Druker, Michael W. Deininger

Blood (2004) 104 (11): 793.

https://doi.org/10.1182/blood.V104.11.793.793

Published: 2004

Journal Articles

Effects of MLN518, a dual FLT3 and KIT inhibitor, on normal and malignant hematopoiesis

Ian J. Griswold, Lei J. Shen, Paul La Rosée, Shadmehr Demehri, Michael C. Heinrich, Rita M. Braziel, Laura McGreevey, Andrea D. Haley, Neill Giese, Brian J. Druker, Michael W.N. Deininger

Blood (2004) 104 (9): 2912–2918.

https://doi.org/10.1182/blood-2003-05-1669

Published: 2004

NARROW

JAK2 V617F Mutation Induces a Myeloproliferative Disorder in Mice.

In vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of Kit

Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970

Investigation of the Biological Differences between Bcr-Abl Kinase Mutations Resistant to Imatinib.

A Bcr-Abl Mutant Lacking Direct Binding Sites for the Grb2, Cbl and CrkL Adapter Proteins Fails to Induce Leukemia in Mice.

In Vitro and In Vivo Activity of the Src/Abl Kinase Inhibitor AP23464 and Analogs Against Activation Loop Mutants of KIT.

Effects of MLN518, a dual FLT3 and KIT inhibitor, on normal and malignant hematopoiesis

Email alerts

ASH Publications

American Society of Hematology

JAK2 V617F Mutation Induces a Myeloproliferative Disorder in Mice.

In vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of Kit

Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970

Investigation of the Biological Differences between Bcr-Abl Kinase Mutations Resistant to Imatinib.

A Bcr-Abl Mutant Lacking Direct Binding Sites for the Grb2, Cbl and CrkL Adapter Proteins Fails to Induce Leukemia in Mice.

In Vitro and In Vivo Activity of the Src/Abl Kinase Inhibitor AP23464 and Analogs Against Activation Loop Mutants of KIT.

Effects of MLN518, a dual FLT3 and KIT inhibitor, on normal and malignant hematopoiesis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only